Form 4: Corcept Therapeutics Director Sells Shares
Insider Transaction (Form 4)
James N Wilson, a Director of Corcept Therapeutics Inc, sold 10,000 shares of common stock on September 15, 2026.
Summary
- Open-market sale: disposed of 6,800 Common Stock at $110.27 ($749,835) on September 15, 2026; holds 1,067,743 after (Indirect).
- Open-market sale: disposed of 400 Common Stock at $110.84 ($44,335) on September 15, 2026; holds 1,067,343 after (Indirect).
- Open-market sale: disposed of 2,800 Common Stock at $111.70 ($312,771) on September 15, 2026; holds 1,064,543 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $1,106,940 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
James N Wilson — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-15 | Open-market sale | Common Stock | 6,800 | $110 | $749.8K | 1,067,743 |
| 2026-09-15 | Open-market sale | Common Stock | 400 | $111 | $44.3K | 1,067,343 |
| 2026-09-15 | Open-market sale | Common Stock | 2,800 | $112 | $312.8K | 1,064,543 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-15 | Open-market sale (6,800 shares) |
| 2026-09-15 | Open-market sale (400 shares) |
| 2026-09-15 | Open-market sale (2,800 shares) |
Keywords
insider transaction, Form 4, CORT, CORCEPT THERAPEUTICS INC, bearish, James N Wilson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.